StockData
Bionano Genomics, Inc. logo

Bionano Genomics, Inc. (BNGO) stock

BNGONasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 12/3083% below fair value
$0.95+0.01 (+1.29%)

Close on Nov 17, 2026Market cap $11.21MP/E –Yield –

Bionano Genomics ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

Bionano Genomics's ebitda for the twelve months ending Jun 30, 2026 was -$22.87M. For fiscal 2025 it was -$23.81M. The highest annual figure on record is -$19.09M in fiscal 2018.

Annual ebitda

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$23.81M–
FY2024Dec 31, 2024-$89.96M–
FY2023Dec 31, 2023-$201.54M–
FY2022Dec 31, 2022-$122.08M–
FY2021Dec 31, 2021-$73.75M–
FY2020Dec 31, 2020-$37.07M–
FY2019Dec 31, 2019-$24.75M–
FY2018Dec 31, 2018-$19.09M–
FY2017Dec 31, 2017-$21.71M–

Quarterly ebitda

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$4.92M–
Q1 FY2026Mar 31, 2026-$5.59M–
Q4 FY2025Dec 31, 2025-$6.20M–
Q3 FY2025Sep 30, 2025-$6.16M–
Q2 FY2025Jun 30, 2025-$5.42M–
Q1 FY2025Mar 31, 2025-$6.03M–
Q4 FY2024Dec 31, 2024-$9.54M–
Q3 FY2024Sep 30, 2024-$38.27M–
Q2 FY2024Jun 30, 2024-$14.03M–
Q1 FY2024Mar 31, 2024-$28.12M–
Q4 FY2023Dec 31, 2023-$21.36M–
Q3 FY2023Sep 30, 2023-$109.59M–
Q2 FY2023Jun 30, 2023-$35.94M–
Q1 FY2023Mar 31, 2023-$34.65M–
Q4 FY2022Dec 31, 2022-$34.76M–
Q3 FY2022Sep 30, 2022-$29.77M–
Q2 FY2022Jun 30, 2022-$29.81M–
Q1 FY2022Mar 31, 2022-$27.73M–
Q4 FY2021Dec 31, 2021-$26.92M–
Q3 FY2021Sep 30, 2021-$20.15M–
Q2 FY2021Jun 30, 2021-$15.96M–
Q1 FY2021Mar 31, 2021-$10.72M–
Q4 FY2020Dec 31, 2020-$10.56M–
Q3 FY2020Sep 30, 2020-$9.91M–
Q2 FY2020Jun 30, 2020-$7.14M–
Q1 FY2020Mar 31, 2020-$9.47M–
Q4 FY2019Dec 31, 2019-$6.85M–
Q3 FY2019Sep 30, 2019-$5.41M–
Q2 FY2019Jun 30, 2019-$6.58M–
Q1 FY2019Mar 31, 2019-$5.92M–
Q4 FY2018Dec 31, 2018-$5.95M–
Q3 FY2018Sep 30, 2018-$5.58M–
Q2 FY2018Jun 30, 2018-$3.63M–
Q1 FY2018Mar 31, 2018-$3.94M–
Q4 FY2017Dec 31, 2017-$4.70M–
Q3 FY2017Sep 30, 2017-$4.79M–

More Bionano Genomics figures

See a number that looks wrong?